AR018178A1 - Derivados de cromanona y tiocromanona, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lapreparacion de un medicamento - Google Patents
Derivados de cromanona y tiocromanona, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lapreparacion de un medicamentoInfo
- Publication number
- AR018178A1 AR018178A1 ARP990101573A ARP990101573A AR018178A1 AR 018178 A1 AR018178 A1 AR 018178A1 AR P990101573 A ARP990101573 A AR P990101573A AR P990101573 A ARP990101573 A AR P990101573A AR 018178 A1 AR018178 A1 AR 018178A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- alkyl
- alkoxy
- pharmaceutical composition
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Abstract
Derivados de cromanona y tiocromanona que comprenden los compuestos de la formula (I), en donde: R1 y R2 son independientemente hidrogeno, acilo,alcoxicarbonilo, o alquilo; cualquier cadena lateral de sulfamoiloxi está enlazada con la posicion 6. R3es alquilo, alquenilo, alquinilo, una fraccion decicloquilo opcionalmente sustituida por alquilo, alcoxi, o halogeno, arilalquilo, arilalquenilo, arilalquinilo, acilo, cicloalquilalquilo, 3-oxo-2-oxacanfanilo; 6,6-dimetilbiciclo-[3.1.1]hept-2-en-2-il o; una fraccion de heteroarilo opcionalmente sustituida por alquilo, alcoxi, o halogeno, o es heteroarilalquilo; y R4 es hidrogeno, alquilo, hidroxi, o alcoxi, o la cadena lateral de sulfamoiloxi está enlazada con la posicion 7; R3 tienen elsignific ado indicadoanteriormente para R4; y R4 tiene el significado indicado anteriormente para R3; X es O o S; y el símbolo - - - es un enlace sencillo o doble; en forma libreo en forma de sal. Estos se pueden preparar mediante la sulfamoilacionde los com puestos hidroxilados correspondientes, mediante reduccion,y/o mediante N-sustitucion. Estos se indican para utilizarse como productos farmacéuticos, particularmente en el tratamiento profiláctico ocurativos de enfermedades que respondan ala inhibici on de sulfatasa de esteroide. Además, describe un proceso para su preparacion, una composicionfarmacéutica que los comprende y el uso de los mismos para la preparacion de un medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9807779.5A GB9807779D0 (en) | 1998-04-09 | 1998-04-09 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018178A1 true AR018178A1 (es) | 2001-10-31 |
Family
ID=10830229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990101573A AR018178A1 (es) | 1998-04-09 | 1999-04-07 | Derivados de cromanona y tiocromanona, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lapreparacion de un medicamento |
Country Status (16)
Country | Link |
---|---|
US (1) | US6346626B1 (es) |
EP (1) | EP1070059B1 (es) |
JP (1) | JP3425424B2 (es) |
AR (1) | AR018178A1 (es) |
AT (1) | ATE224885T1 (es) |
AU (1) | AU3605499A (es) |
CO (1) | CO5031242A1 (es) |
DE (1) | DE69903143T2 (es) |
DK (1) | DK1070059T3 (es) |
ES (1) | ES2184439T3 (es) |
GB (1) | GB9807779D0 (es) |
MY (1) | MY118897A (es) |
PE (1) | PE20000419A1 (es) |
PT (1) | PT1070059E (es) |
TW (1) | TW513420B (es) |
WO (1) | WO1999052890A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5261573A1 (es) | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
JP2002020362A (ja) * | 2000-07-06 | 2002-01-23 | Nippon Oruganon Kk | 新規ビフェニル誘導体 |
GB0020498D0 (en) | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
GB0127923D0 (en) | 2001-11-21 | 2002-01-16 | Sterix Ltd | Compound |
PL211300B1 (pl) | 2002-04-17 | 2012-05-31 | Cytokinetics Inc | Związek i kompozycja zawierająca ten związek |
EP1514557A1 (en) * | 2002-06-19 | 2005-03-16 | Takeda Chemical Industries, Ltd. | Preventives/remedies for bone and joint diseases |
JP2005533119A (ja) | 2002-07-17 | 2005-11-04 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、及び方法 |
DE10260955A1 (de) * | 2002-12-20 | 2004-07-08 | Henkel Kgaa | Verwendung von Steroidsulfatase-Inhibitoren zur Verminderung von Haarausfall |
TW200524588A (en) * | 2003-09-22 | 2005-08-01 | Nippon Shinyaku Co Ltd | Hair restorer |
MXPA06006837A (es) | 2003-12-15 | 2006-09-04 | Theramex | Derivados de 1-n-fenil-amino-ih-imidazol y composiciones farmaceuticas que los contienen. |
GB0411562D0 (en) | 2004-05-24 | 2004-06-23 | Sterix Ltd | Compound |
GB0412492D0 (en) | 2004-06-04 | 2004-07-07 | Sterix Ltd | Compound |
GB0505541D0 (en) * | 2005-03-17 | 2005-04-27 | Novartis Ag | Organic compounds |
GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
GB0604142D0 (en) | 2006-03-01 | 2006-04-12 | Sterix Ltd | Compound |
GB0706072D0 (en) | 2007-03-28 | 2007-05-09 | Sterix Ltd | Compound |
JP5543920B2 (ja) | 2007-09-17 | 2014-07-09 | プレグレム エスアー | 閉経前の女性におけるエストロゲン依存症状の治療 |
GB0722779D0 (en) | 2007-11-20 | 2008-01-02 | Sterix Ltd | Compound |
GB0914767D0 (en) | 2009-08-24 | 2009-09-30 | Sterix Ltd | Compound |
EP2598138B1 (en) * | 2010-07-27 | 2020-05-06 | Trustees of Boston University | Aryl hydrocarbon receptor (ahr) modifiers as novel cancer therapeutics |
EP3260445A1 (en) * | 2016-06-24 | 2017-12-27 | Universität Konstanz | Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor |
EP3502095A1 (en) | 2017-12-22 | 2019-06-26 | Universität Konstanz | Compound for use against pathogenic neisseria and haemophilus species and moraxella catarrhalis |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH619701A5 (es) * | 1975-08-07 | 1980-10-15 | Bayer Ag | |
US4060619A (en) * | 1976-01-14 | 1977-11-29 | Ayerst Mckenna And Harrison Ltd. | 1,4-Dihydro-4-oxo-benzothiopyrano (4,3-b)pyridine-2-carboxylates and derivatives |
DE3243158A1 (de) | 1982-11-23 | 1984-05-24 | Basf Ag, 6700 Ludwigshafen | Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel |
FR2543140B1 (fr) | 1983-03-24 | 1985-06-21 | Cortial | Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique |
IN164232B (es) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
GB8800199D0 (en) | 1988-01-06 | 1988-02-10 | Beecham Group Plc | Pharmaceutical preparation |
PT94305B (pt) | 1989-06-12 | 1997-02-28 | Robins Co Inc A H | Processo para a preparacao de compostos tendo um ou mais radicais aminossulfoniloxi uteis como produtos farmaceuticos |
US5273993A (en) | 1989-06-12 | 1993-12-28 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
US5194446A (en) | 1989-06-12 | 1993-03-16 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
US5025031A (en) | 1989-11-30 | 1991-06-18 | A. H. Robins Co., Inc. | Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants |
GB9118478D0 (en) | 1991-08-29 | 1991-10-16 | Imperial College | Steroid sulphatase inhibitors |
GB9603325D0 (en) | 1996-02-16 | 1996-04-17 | Imperial College | A compound |
DE4308451A1 (de) | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
WO1995026717A1 (en) | 1994-04-05 | 1995-10-12 | Celltech Therapeutics Limited | Use of estrone derivatives as steroid sulphatase inhibitors |
US5556847A (en) | 1994-10-27 | 1996-09-17 | Duquesne University Of The Holy Ghost | Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors |
US5567831A (en) | 1995-08-16 | 1996-10-22 | Duguesne University Of The Holy Ghost | Non-steroidal sulfatase inhibitor compounds and their method of use |
DE19532311A1 (de) | 1995-09-01 | 1997-03-06 | Basf Ag | Benzoylderivate |
ATE286038T1 (de) * | 1996-03-05 | 2005-01-15 | Sterix Ltd | Verbindungen mit sulfonsäure-amidgruppe |
WO1998008836A1 (fr) * | 1996-08-27 | 1998-03-05 | Shionogi & Co., Ltd. | Derives de chromene-3-carboxylate |
US5763492A (en) | 1996-10-01 | 1998-06-09 | Duguesne University Of The Holy Ghost | Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors |
US6028088A (en) * | 1998-10-30 | 2000-02-22 | The University Of Mississippi | Flavonoid derivatives |
-
1998
- 1998-04-09 GB GBGB9807779.5A patent/GB9807779D0/en not_active Ceased
-
1999
- 1999-03-31 CO CO99019386A patent/CO5031242A1/es unknown
- 1999-04-02 TW TW088105316A patent/TW513420B/zh not_active IP Right Cessation
- 1999-04-07 DE DE69903143T patent/DE69903143T2/de not_active Expired - Lifetime
- 1999-04-07 MY MYPI99001329A patent/MY118897A/en unknown
- 1999-04-07 PT PT99917963T patent/PT1070059E/pt unknown
- 1999-04-07 JP JP2000543450A patent/JP3425424B2/ja not_active Expired - Fee Related
- 1999-04-07 WO PCT/EP1999/002349 patent/WO1999052890A1/en active IP Right Grant
- 1999-04-07 AU AU36054/99A patent/AU3605499A/en not_active Abandoned
- 1999-04-07 ES ES99917963T patent/ES2184439T3/es not_active Expired - Lifetime
- 1999-04-07 EP EP99917963A patent/EP1070059B1/en not_active Expired - Lifetime
- 1999-04-07 DK DK99917963T patent/DK1070059T3/da active
- 1999-04-07 AR ARP990101573A patent/AR018178A1/es unknown
- 1999-04-07 AT AT99917963T patent/ATE224885T1/de not_active IP Right Cessation
- 1999-04-07 PE PE1999000280A patent/PE20000419A1/es not_active Application Discontinuation
-
2000
- 2000-10-06 US US09/680,887 patent/US6346626B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2184439T3 (es) | 2003-04-01 |
WO1999052890A1 (en) | 1999-10-21 |
JP2002511459A (ja) | 2002-04-16 |
DK1070059T3 (da) | 2002-12-16 |
PE20000419A1 (es) | 2000-05-29 |
CO5031242A1 (es) | 2001-04-27 |
TW513420B (en) | 2002-12-11 |
DE69903143D1 (de) | 2002-10-31 |
PT1070059E (pt) | 2003-01-31 |
AU3605499A (en) | 1999-11-01 |
JP3425424B2 (ja) | 2003-07-14 |
US6346626B1 (en) | 2002-02-12 |
MY118897A (en) | 2005-02-28 |
ATE224885T1 (de) | 2002-10-15 |
GB9807779D0 (en) | 1998-06-10 |
DE69903143T2 (de) | 2003-06-05 |
EP1070059A1 (en) | 2001-01-24 |
EP1070059B1 (en) | 2002-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR018178A1 (es) | Derivados de cromanona y tiocromanona, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lapreparacion de un medicamento | |
AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
ES2093440T3 (es) | Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos. | |
HRP20050781B1 (hr) | Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu | |
UY26839A1 (es) | Productos de derivados de la 4 - fenil - piridina | |
EE200200110A (et) | Etinüülöstradiooli ja drospirenooni farmatseutiline kombinatsioon kasutamiseks rasestumisvastase vahendina | |
BR9607565A (pt) | Derivados de hidroxilamina úteis para produção de protetores moleculares e sua preparação | |
MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
TW200420549A (en) | Thiazole derivatives | |
AR012504A1 (es) | Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion. | |
AR022204A1 (es) | Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende. | |
BRPI0607999A2 (pt) | método para o alìvio de sintomas, o tratamento ou a prevenção do cáncer, uso de uma quantidade eficaz de um ou mais derivados de fosfato de um ou mais hidróxi cromanos selecionados do grupo que consiste em 7:8-dimetil 6-hidróxi cromanos (delta), 8-metil 6-hidróxi cromanos (gama), e as misturas dos mesmos, conjuntamente com um veìculo ou um diluente apropriado, método para a indução da apoptose celular, método para aumentar a eficácia de um agente anticáncer, método para aumentar a eficácia do licopeno, formulação farmacêutica | |
AR013001A1 (es) | Derivados de la piperazina, procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, su utilizacion como medicamentoy el metodo para tratar enfermedades mediadas por la taquinina. | |
PE20031044A1 (es) | Derivados de fenilimidazolidina y proceso de preparacion | |
PL1682528T3 (pl) | Pochodne benzo[b][1,4]dioksepiny | |
AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
BR0115306A (pt) | Composto, prodroga, composição farmacêutica, agente para diminuir androgênio, método para a produção de um composto, e, sal diastereomérico | |
ES2191449T3 (es) | Derivados de ciclopentabenzofurano y su uso. | |
BR0008437A (pt) | Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos | |
TR200101163T2 (tr) | Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları | |
HUP9903747A2 (hu) | Új eljárás mometazon-furoát előállítására | |
SE0200475D0 (sv) | Oral farmaceutisk beredning | |
PA8531601A1 (es) | Nuevos heteroaromatos | |
PA8509601A1 (es) | "PIRAZOLO [4,3,e] DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN, SU USO COMO PRODUCTOS MEDICINALES Y PROCESOS PARA PREPARARLAS | |
AR010857A1 (es) | Esteroides sustituidos en la posicion 11, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que loscontienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |